Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Syrjänen R[au]:

Search results

Items: 38

1.

Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data: The Finnish example.

Baum U, Auranen K, Kulathinal S, Syrjänen R, Nohynek H, Jokinen J.

Scand J Public Health. 2018 Nov 2:1403494818808635. doi: 10.1177/1403494818808635. [Epub ahead of print]

PMID:
30387371
2.

The prevalence of otitis media in 2-3 year old Cameroonian children estimated by tympanometry.

Libwea JN, Kobela M, Ndombo PK, Syrjänen RK, Huhtala H, Fointama N, Koulla-Shiro S, Nohynek H, Nuorti JP, Palmu AA.

Int J Pediatr Otorhinolaryngol. 2018 Dec;115:181-187. doi: 10.1016/j.ijporl.2018.10.007. Epub 2018 Oct 6.

3.

Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.

Rondy M, Gherasim A, Casado I, Launay O, Rizzo C, Pitigoi D, Mickiene A, Marbus SD, Machado A, Syrjänen RK, Pem-Novose I, Horváth JK, Larrauri A, Castilla J, Vanhems P, Alfonsi V, Ivanciuc AE, Kuliese M, van Gageldonk-Lafeber R, Gomez V, Ikonen N, Lovric Z, Ferenczi A, Moren A; I-MOVE+ hospital working group.

Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.17-00645.

4.

2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.

Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, Syrjänen RK, Gefenaite G, Machado A, Vučina VV, Horváth JK, Paradowska-Stankiewicz I, Marbus SD, Gherasim A, Díaz-González JA, Rizzo C, Ivanciuc AE, Galtier F, Ikonen N, Mickiene A, Gomez V, Kurečić Filipović S, Ferenczi A, Korcinska MR, van Gageldonk-Lafeber R; I-MOVE+ hospital working group, Valenciano M.

Euro Surveill. 2017 Jul 27;22(30). pii: 30580. doi: 10.2807/1560-7917.ES.2017.22.30.30580.

5.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
6.

Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza.

Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barberà J, Gefenaite G, Larrauri A, Rizzo C, Pitigoi D, Syrjänen RK, Machado A, Kurečić Filipović S, Krisztina Horváth J, Paradowska-Stankiewicz I, Marbus S; InNHOVE/I-MOVE+working group, Moren A.

Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11.

7.

Leucocyte protein Trojan, a possible regulator of apoptosis.

Petrov P, Syrjänen R, Uchida T, Vainio O.

APMIS. 2017 Feb;125(2):106-113. doi: 10.1111/apm.12641. Epub 2016 Dec 28.

PMID:
28028869
8.

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16.

Nohynek H, Baum U, Syrjänen R, Ikonen N, Sundman J, Jokinen J.

Euro Surveill. 2016 Sep 22;21(38). doi: 10.2807/1560-7917.ES.2016.21.38.30346.

9.

New Pneumococcal Carriage Acquired in Association with Acute Respiratory Infection Is Prone to Cause Otitis Media.

Auranen K, Syrjänen R, Leino T, Kilpi T.

PLoS One. 2016 Jun 3;11(6):e0156343. doi: 10.1371/journal.pone.0156343. eCollection 2016.

10.

Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.

Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.

J Infect Dis. 2016 Jun 15;213(12):2005-13. doi: 10.1093/infdis/jiw058. Epub 2016 Feb 9.

PMID:
26908733
11.

Health benefit for the child and promotion of the common good were the two most important reasons for participation in the FinIP vaccine trial.

Nieminen H, Syrjänen RK, Puumalainen T, Sirén P, Palmu AA.

Vaccine. 2015 Jul 17;33(31):3695-702. doi: 10.1016/j.vaccine.2015.06.010. Epub 2015 Jun 11.

PMID:
26073011
12.

Characterization of the avian Trojan gene family reveals contrasting evolutionary constraints.

Petrov P, Syrjänen R, Smith J, Gutowska MW, Uchida T, Vainio O, Burt DW.

PLoS One. 2015 Mar 24;10(3):e0121672. doi: 10.1371/journal.pone.0121672. eCollection 2015.

13.

Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.

Syrjänen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, Kilpi TM.

PLoS One. 2014 Sep 29;9(9):e108538. doi: 10.1371/journal.pone.0108538. eCollection 2014.

14.

Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.

Palmu AA, Jokinen J, Nieminen H, Syrjänen R, Ruokokoski E, Puumalainen T, Moreira M, Schuerman L, Borys D, Kilpi TM.

Lancet Respir Med. 2014 Sep;2(9):717-27. doi: 10.1016/S2213-2600(14)70139-0. Epub 2014 Aug 7.

PMID:
25127244
15.

TIM-family molecules in embryonic hematopoiesis: fetal liver TIM-4(lo) cells have myeloid potential.

Syrjänen R, Petrov P, Glumoff V, Fang S, Salven P, Savolainen ER, Vainio O, Uchida T.

Exp Hematol. 2014 Mar;42(3):230-40. doi: 10.1016/j.exphem.2013.11.014. Epub 2013 Dec 4.

PMID:
24316337
16.

No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.

Melén K, Partinen M, Tynell J, Sillanpää M, Himanen SL, Saarenpää-Heikkilä O, Hublin C, Olsen P, Ilonen J, Nohynek H, Syrjänen R, Kilpi T, Vuorela A, Kirjavainen T, Vaarala O, Julkunen I.

PLoS One. 2013 Aug 8;8(8):e68402. doi: 10.1371/journal.pone.0068402. eCollection 2013.

17.

Comparative analysis of Streptococcus pneumoniae transmission in Portuguese and Finnish day-care centres.

Pessoa D, Hoti F, Syrjänen R, Sá-Leão R, Kaijalainen T, Gomes MG, Auranen K.

BMC Infect Dis. 2013 Apr 18;13:180. doi: 10.1186/1471-2334-13-180.

18.

Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres.

Leino T, Hoti F, Syrjänen R, Tanskanen A, Auranen K.

BMC Infect Dis. 2008 Dec 30;8:173. doi: 10.1186/1471-2334-8-173.

19.

Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age.

Kilpi TM, Silfverdal SA, Nilsson L, Syrjänen R, Belloni C, Desole M, Triban C, Storsaeter J, Soila M, Jacquet JM.

Hum Vaccin. 2009 Jan-Feb;5(1):18-25. Epub 2009 Jan 2.

PMID:
18690013
20.

The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age.

Syrjänen RK, Herva EE, Mäkelä PH, Puhakka HJ, Auranen KJ, Takala AK, Kilpi TM.

Pediatr Infect Dis J. 2006 Nov;25(11):1032-6.

PMID:
17072126
21.

Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage.

Syrjänen RK, Auranen KJ, Leino TM, Kilpi TM, Mäkelä PH.

Pediatr Infect Dis J. 2005 Sep;24(9):801-6.

PMID:
16148847
22.

Using multilocus sequence data to define the pneumococcus.

Hanage WP, Kaijalainen T, Herva E, Saukkoriipi A, Syrjänen R, Spratt BG.

J Bacteriol. 2005 Sep;187(17):6223-30.

23.

Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children?

Kleemola M, Nokso-Koivisto J, Herva E, Syrjänen R, Lahdenkari M, Kilpi T, Hovi T.

J Infect. 2006 Mar;52(3):181-7. Epub 2005 Jun 29.

PMID:
15992930
24.

Diagnostic value of tympanometry using subject-specific normative values.

Palmu AA, Syrjänen R.

Int J Pediatr Otorhinolaryngol. 2005 Jul;69(7):965-71. Epub 2005 Mar 16.

PMID:
15911016
25.

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland.

Hanage WP, Kaijalainen TH, Syrjänen RK, Auranen K, Leinonen M, Mäkelä PH, Spratt BG.

Infect Immun. 2005 Jan;73(1):431-5.

26.

Impact of antimicrobial exposure and beta-lactamase-producing bacteria on salivary beta-lactamase activity in infancy.

Nyfors S, Syrjänen R, Könönen E.

Int J Antimicrob Agents. 2004 Nov;24(5):463-7.

PMID:
15519478
27.

Type-specific enzyme immunoassay for detection of pneumococcal capsular polysaccharide antigens in nasopharyngeal specimens.

Lankinen KS, Rintamäki S, Syrjänen R, Kilpi T, Ruutu P, Leinonen M.

J Microbiol Methods. 2004 Feb;56(2):193-9.

PMID:
14744448
28.

Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.

Nokso-Koivisto J, Räty R, Blomqvist S, Kleemola M, Syrjänen R, Pitkäranta A, Kilpi T, Hovi T.

J Med Virol. 2004 Feb;72(2):241-8.

PMID:
14695665
29.

Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines.

Hanage WP, Auranen K, Syrjänen R, Herva E, Mäkelä PH, Kilpi T, Spratt BG.

Infect Immun. 2004 Jan;72(1):76-81.

30.

Age-related frequency of penicillin resistance of oral Veillonella.

Nyfors S, Könönen E, Bryk A, Syrjänen R, Jousimies-Somer H.

Diagn Microbiol Infect Dis. 2003 Aug;46(4):279-83.

PMID:
12944020
31.

Nasopharyngeal carriage of anaerobes during health and acute otitis media by two years of age.

Könönen E, Syrjänen R, Takala A, Jousimies-Somer H.

Diagn Microbiol Infect Dis. 2003 Jul;46(3):167-72.

PMID:
12867091
32.

Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood.

Nyfors S, Könönen E, Syrjänen R, Komulainen E, Jousimies-Somer H.

J Antimicrob Chemother. 2003 Jan;51(1):107-12.

PMID:
12493794
33.

Common respiratory infections early in life may reduce the risk of atopic dermatitis.

Kilpi T, Kero J, Jokinen J, Syrjänen R, Takala AK, Hovi T, Isolauri E.

Clin Infect Dis. 2002 Mar 1;34(5):620-6. Epub 2002 Jan 24.

PMID:
11810601
34.

Negative pressure tympanograms in children less than 2 years of age--different bacterial findings in otitis media by tympanometric results.

Palmu A, Syrjänen R, Kilpi T, Pursiainen H, Puhakka H, Rahko T, Herva E, Takala A.

Int J Pediatr Otorhinolaryngol. 2001 Oct 19;61(1):61-9.

PMID:
11576632
35.

Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.

Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK.

J Infect Dis. 2001 Aug 15;184(4):451-9. Epub 2001 Jul 6.

PMID:
11471103
36.

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

Kilpi T, Herva E, Kaijalainen T, Syrjänen R, Takala AK.

Pediatr Infect Dis J. 2001 Jul;20(7):654-62.

PMID:
11465836
37.

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Rapola S, Jäntti V, Haikala R, Syrjänen R, Carlone GM, Sampson JS, Briles DE, Paton JC, Takala AK, Kilpi TM, Käyhty H.

J Infect Dis. 2000 Oct;182(4):1146-52. Epub 2000 Sep 5.

PMID:
10979911
38.

Age-related acquisition of oral and nasopharyngeal yeast species and stability of colonization in young children.

Hannula J, Saarela M, Jousimies-Somer H, Takala A, Syrjänen R, Könönen E, Asikainen S.

Oral Microbiol Immunol. 1999 Jun;14(3):176-82.

PMID:
10495712

Supplemental Content

Loading ...
Support Center